Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Manufacturing	4.58B	4.45B	3.96B	3.39B	3.61B
Pharmaceutical Manufacturing Growth	2.97%	12.49%	16.78%	-6.01%	9.44%
Unallocated Other Business	1.88M	1.49M	626.85K	635.74K	186.83K
Unallocated Other Business Growth	26.16%	137.39%	-1.40%	240.28%	-85.32%
Total	4.59B	4.45B	3.96B	3.39B	3.61B
Total Growth	2.98%	12.51%	16.77%	-6.00%	9.40%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Northeast China	352.46M	300.93M	262.54M	211.53M	218.52M
Northeast China Growth	17.13%	14.62%	24.11%	-3.20%	-20.52%
North China	606.94M	580.38M	510.03M	412.62M	425.48M
North China Growth	4.58%	13.79%	23.61%	-3.02%	42.15%
East China	1.24B	1.20B	1.06B	932.25M	1.04B
East China Growth	3.08%	12.74%	14.17%	-10.40%	3.10%
South China	1.14B	1.13B	985.71M	887.00M	918.75M
South China Growth	0.80%	14.90%	11.13%	-3.46%	12.24%
Northwest China	410.54M	397.36M	363.54M	285.19M	314.24M
Northwest China Growth	3.32%	9.30%	27.47%	-9.25%	6.67%
Southwest China	834.20M	824.60M	762.71M	653.77M	686.25M
Southwest China Growth	1.16%	8.11%	16.66%	-4.73%	15.57%
Overseas	478.88K	15.29M	7.93M	6.02M	1.42M
Overseas Growth	-96.87%	92.97%	31.59%	324.06%	-62.06%
Unallocated	1.88M	1.49M	626.85K	635.74K	186.83K
Unallocated Growth	26.16%	137.39%	-1.40%	240.28%	-85.32%
Total	4.59B	4.45B	3.96B	3.39B	3.61B
Total Growth	2.98%	12.51%	16.77%	-6.00%	9.40%

Source: S&P Global Market Intelligence.